EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effect and Safety of Bronchoscopy Based on Imaging Evaluation in Patients With Acute Exacerbation of Bronchiectasis

Biliang Li, Zeng Juan, Mingfeng Wang, Wei Kang, Bo Li iD

Canadian Respiratory Journal · 2026-01 · 2026 (1)

DOI: 10.1155/carj/3117887 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Canadian Respiratory Journal, online erschienen am 04.06.2026. Verfasst von Biliang Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Bazhong Central Hospital, Bazhong, 636000, Sichuan, China, scu.edu.cn. Hauptthemen laut MEDLINE: Bronchoscopy, Bronchiectasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the efficacy and safety of imaging‐assisted bronchoscopic interventions in acute bronchiectasis exacerbations and analyze their effects on pulmonary function, inflammation, and quality of life for evidence‐based clinical support.

Methods

A total of 80 inpatients with acute bronchiectasis exacerbations were randomized into a control group ( n = 40), receiving conventional anti‐infective and symptomatic treatment, and an intervention group ( n = 40), receiving additional imaging‐assisted bronchoscopic intervention. Pulmonary function, inflammatory markers (C‐reactive protein [CRP], procalcitonin [PCT], and white blood cell count [WBC]), and St George’s Respiratory Questionnaire (SGRQ) quality of life scores were assessed preintervention and at 1, 2, and 4 weeks. Adverse events (e.g., hemoptysis, pneumothorax, and infection spread) and overall effectiveness were recorded.

Results

No significant intergroup differences were observed in baseline characteristics, preintervention pulmonary function (forced expiratory volume in the first second [FEV 1 ], forced vital capacity [FVC], and FEV 1 /FVC), inflammatory markers (CRP, PCT, and WBC), or SGRQ scores ( p > 0.05). After 1, 2, and 4 weeks, the intervention group demonstrated significantly greater improvements: higher FEV 1 , lower CRP and PCT levels, and reduced SGRQ scores compared with the control group ( p < 0.05). The generalized estimation equation (GEE) model revealed that the improvement magnitude in the intervention group increased over time ( p < 0.001). The overall adverse event rate in the intervention group was 10.00% (4/40), significantly lower than the control group’s 37.50% (15/40); the total effective rate was 92.50% (37/40), surpassing the control group’s 70.00% (28/40) ( p < 0.05).

Conclusion

Bronchoscopy intervention guided by imaging improves lung function, reduces inflammation and adverse events, enhances quality of life, and demonstrates good safety with high clinical value in acute bronchiectasis exacerbations. The therapeutic benefit is likely attributable to the bronchoscopic procedure itself, including targeted pathogen identification and subsequent antibiotic modification, rather than solely to transient sputum clearance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BronchoscopyBronchiectasisHumansFemaleMaleQuality of LifeAgedMiddle AgedC-Reactive ProteinDisease ProgressionRespiratory Function TestsTreatment OutcomeProcalcitoninAcute Disease

Stichwörter der Autor:innen

acute exacerbationbronchiectasisbronchoscopy interventional technologyimaging evaluationsafety

Substanzen

C-Reactive ProteinProcalcitonin

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Bazhong Central Hospital, Bazhong, 636000, Sichuan, China, scu.edu.cn.

ORCID-Profile: Bo Li

Zitieren

APA

Li, B., Juan, Z., Wang, M., Kang, W., & Li, B. (2026). Effect and Safety of Bronchoscopy Based on Imaging Evaluation in Patients With Acute Exacerbation of Bronchiectasis. Canadian Respiratory Journal, 2026(1). https://doi.org/10.1155/carj/3117887

Vancouver

Li B, Juan Z, Wang M, Kang W, Li B. Effect and Safety of Bronchoscopy Based on Imaging Evaluation in Patients With Acute Exacerbation of Bronchiectasis. Canadian Respiratory Journal. 2026;2026(1). doi:10.1155/carj/3117887

BibTeX
@article{Li2026,
  author = {Li, Biliang and Juan, Zeng and Wang, Mingfeng and Kang, Wei and Li, Bo},
  title = {Effect and Safety of Bronchoscopy Based on Imaging Evaluation in Patients With Acute Exacerbation of Bronchiectasis},
  journal = {Canadian Respiratory Journal},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/carj/3117887}
}
Kostenlos starten →